Catalyst Wire Dossier Catalyst Wire Dossier

Abilify Prolonged Release Aqueous Suspension for IM Injection

aripiprazole · Otsuka Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Abilify Prolonged Release Aqueous Suspension for IM Injection, covering 2025-03-21 to 2025-03-21. Get the full timeline:

Most recent: Clinical Trial Update: Specified Drug-use Survey on Abilify Prolonged Release Aqueous Suspension for IM Injection (Prevention of Relapse of Mood Episodes in BP)

See pricing